• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Know Labs wins new glucose monitoring patent

January 4, 2023 By Sean Whooley

Know Labs KnowU Uband non-invasive glucose monitor
[Image from Know Labs]
Know Labs (NYSE:KNW) announced today that it received a new patent equating its diagnostic technology to the current glucose monitoring standard.

Seattle-based Know Labs develops the Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. It integrate into wearable, mobile or bench-top form factors. The first application of the technology comes in the form of a non-invasive glucose monitor.

The company’s new patent equates the technology to mean absolute relative difference, or MARD. This standard, used by diabetes researchers and glucose meter makers, establishes a range of clinical accuracy. Know Labs said the patent expands its IP portfolio to nearly 90 patents issued and pending.

“Intellectual property development is a critical pillar of our success,” said Ron Erickson, Know Labs founder and chair. “We make significant investments in the strategic development of our IP portfolio, which creates long-term value for our shareholders, improves our competitive position and accelerates our efforts to bring the first FDA-cleared, truly non-invasive glucose monitoring device to the market.”

This patent explicitly designates a MARD range between 5% and 9.9% for the non-invasive diagnostics platform. It falls equal to superior to MARD readings of any FDA-cleared blood glucose monitoring products, Know Labs said.

More about the Know Labs glucose monitoring technology

Bio-RFID technology uses time-frequency synchronization and decoupled antenna designs.

Know Labs said this enables the collection of a “massive amount” of data signals across real-time glucose concentrations. These cover interstitial fluid, capillary and venous blood and cellular tissue. The company said its sensor penetrates to an average of 0.5 inches, based on internal estimates. This compares to the typical penetration of 0.2 inches with common minimally invasive CGMs, the company added.

The company said its non-invasive technology could “become the new reference standard for glucose testing.”

“We believe this is the first and only patent granted with a MARD range in its claims,” Erickson added. “This is a significant milestone for Know Labs and for the non-invasive glucose monitoring industry, as it sets a new benchmark for MARD among all glucose sensors, invasive or not. We remain highly confident in our plans as we continue executing toward the FDA clearance process.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Know Labs

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS